Vicarious Surgical Inc. - רווח החברה לפני מסים, ריבית ופחת RBOT

Vicarious Surgical Inc. develops advanced robots for minimally invasive interventions, leveraging investment capital to commercialize its systems. Focusing on the B2B segment, the company simplifies abdominal surgeries while reducing clinic costs. The brand is currently scaling the delivery of precision platforms for the automation of micro-movements. The GURU.Markets platform broadcasts the company's operating profit, where the 0.00 indicator determines the metric's value, helping to identify market anomalies.

High robot development costs and uncertainty regarding FDA certification timelines are exerting significant pressure on the cash flows of Vicarious Surgical Inc. (RBOT). By analyzing aggregated EBITDA, investors assess the business's daily capacity to generate operating profit net of inflationary costs, which helps determine the real cost of capital amid limited liquidity and high Fed rates.